Question 1

Does BlackRock own SRPT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 18,994,958 shares of SRPT (Sarepta Therapeutics), worth $341.3M.

Question 2

How many shares of SRPT does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 18,994,958 shares of SRPT (Sarepta Therapeutics).

Question 3

What is BlackRock's SRPT position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's SRPT position is worth $341.3M.

Question 4

Is BlackRock buying or selling SRPT?

Accepted Answer

In Q2 2026, BlackRock increased its SRPT position by 4,239,681 shares (+28.7%).

Question 5

When did BlackRock first buy SRPT?

Accepted Answer

BlackRock already held SRPT in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	19M	+28.7%	$341.3M	0.0%	$17.97	39
2026-Q1	Increased	14.8M	+3.3%	$321.1M	0.0%	$21.76	32
2025-Q4	Increased	14.3M	+8.2%	$307.4M	0.0%	$21.52	34
2025-Q3	Increased	13.2M	+8.9%	$254.4M	0.0%	$19.27	34
2025-Q2	Increased	12.1M	+22.3%	$207.2M	0.0%	$17.10	37
2025-Q1	Decreased	9.9M	-11.5%	$632.3M	0.0%	$63.82	0
2024-Q4	Increased	11.2M	+1.5%	$1.4B	0.0%	$121.59	32
2024-Q3	First report	11M	-	$1.4B	0.0%	$124.89	0

SRPT8 quarters

SRPT
8 quarters